Core technology across both projects — plasma coating process development in NextGen (coordinator) and ALD/MLD hybrid coating science in HYCOAT (partner).
EUROPLASMA NV
Belgian SME specializing in plasma nanocoating deposition for industrial filtration, biomedical, and packaging applications.
Their core work
EUROPLASMA NV is a Belgian SME that develops and applies plasma-based deposition technology to create functional nanocoatings on industrial substrates. Their core capability is transforming surface properties through plasma processes — coating nonwoven filters, packaging materials, biomedical devices, and electronic components with thin functional layers that add barrier, biocompatible, or performance-enhancing properties. They participated in a major European training network for molecular and atomic layer deposition, indicating both strong research connections and deep technical expertise in advanced coating chemistry. Their SME Instrument project positions them as a company actively moving plasma coating technology from laboratory to industrial-scale production.
What they specialise in
HYCOAT (2018-2022) was a European Training Network specifically for functional hybrid coatings by molecular layer deposition, where EUROPLASMA contributed industrial expertise.
NextGen (2020) targeted industrial breakthrough of plasma-deposited nanocoatings specifically for nonwoven filter applications.
HYCOAT covered biomedical coating and encapsulation/packaging applications within its hybrid coating research scope.
Low-k dielectrics and thermo-electric generator applications were among the target use cases explored in HYCOAT.
How they've shifted over time
In their earlier work (HYCOAT, from 2018), EUROPLASMA engaged with the full spectrum of ALD/MLD hybrid coating science — spanning packaging, biomedical, electronics (low-k dielectrics), and energy applications (batteries, thermoelectrics). By 2020, their own SME Instrument project (NextGen) shows a deliberate narrowing toward plasma nanocoating as a distinct industrial process and toward filtration as a concrete commercial target. The shift from broad coating research participation to leading a focused plasma commercialization project suggests a company that used academic collaboration to sharpen its industrial niche rather than to diversify endlessly.
EUROPLASMA is moving from broad coating research participation toward industrial commercialization of plasma nanocoating technology, with filtration as their current market entry point.
How they like to work
EUROPLASMA operates at both ends of the collaboration spectrum — as an industrial partner in a large MSCA training network (HYCOAT, 25 consortium partners) and as coordinator of a focused SME Instrument project (NextGen). Their participation in HYCOAT without direct EC funding suggests they contributed industrial expertise in exchange for research access, a typical arrangement for technology SMEs in academic training networks. This pattern — learning through large consortia, then leading focused commercial applications — indicates a company that uses EU projects strategically for technology development rather than primarily for funding.
EUROPLASMA has worked with 25 consortium partners across 9 countries, primarily through the large HYCOAT training network. Their network spans European research institutions and industrial partners, with Belgium as the home base and no single dominant geographic cluster visible from the data.
What sets them apart
EUROPLASMA is a rare Belgian SME sitting at the intersection of plasma physics and industrial coating engineering — a combination that is technically demanding and commercially valuable for surface functionalization at scale. Unlike university groups working on coating science, they bring process engineering and industrial deployment capability. Their ability to contribute to academic training networks while independently coordinating commercialization projects makes them a credible bridge between coating research and manufacturing industry.
Highlights from their portfolio
- NextGenAs coordinator of this SME Instrument Phase 1 project, EUROPLASMA secured direct EU validation of their plasma nanocoating technology for the filtration market — a focused commercial proof-of-concept with EUR 50,000 in EC funding.
- HYCOATParticipation in this MSCA Innovative Training Network alongside major European research institutions demonstrates EUROPLASMA's standing as an industrial reference in advanced ALD/MLD coating technology, despite receiving no direct EC funding.